$CUR Recent News This tiny biotech company takes the

New Post Public Reply Private Reply Replies (0) Message Board

Jan 7, 2015 at 1:16 PM

$CUR Recent News

This tiny biotech company takes the real ice bucket challenge 9:14 a.m. Sept. 2, 2014 - Michael Brush
Neuralstem gets FDA okay for depression study 9:28 a.m. Oct. 17, 2012 - MarketWatch.com
Stocks to watch Monday: LDK, OfficeMax 4:27 p.m. Sept. 14, 2012 - William Spain
Friday’s biggest gaining and declining stocks 4:11 p.m. Sept. 14, 2012 - MarketWatch
Hot stocks to watch 6:14 a.m. Sept. 14, 2012 - MarketWatch.com
Stocks to watch Friday: Werner, Libbey, Delphi 6:07 a.m. Sept. 14, 2012 - MarketWatch
Canada hot stocks: Scotiabank, Great Panther 2:29 p.m. Aug. 30, 2011 - MarketWatch
Are stem-cell stocks a good buy? 2:06 p.m. July 13, 2011 - Val Brickates Kennedy
Drug stocks mixed after Fed statement 1:02 p.m. June 22, 2011 - Val Brickates Kennedy
Drug stocks gain while Nanosphere sinks 1:12 p.m. June 21, 2011 - Val Brickates Kennedy
Neuralstem soars on FDA move 2:00 p.m. Feb. 9, 2011 - Val Brickates Kennedy
Neuralstem, Impax in drug-sector spotlight 3:22 p.m. Dec. 16, 2010 - Val Brickates Kennedy
Neuralstem climbs as drug indexes hug flat line 10:02 a.m. Dec. 16, 2010 - Val Brickates Kennedy
Neuralstem soars on FDA nod 9:16 a.m. Dec. 16, 2010 - Val Brickates Kennedy
Before the Close Report from the MarketWatch Radio Network 1:31 p.m. March 9, 2009 - Andrew O'Day
Geron's study OK signals progress for company, stem cell peers 1:13 p.m. Jan. 23, 2009 - MarketWatch.com
2007 could emerge as a pivotal year for stem-cell investing 5:43 p.m. Dec. 12, 2007 - Scott Austin
Palatin plunges on drug setback; Atherogenics continues rally 12:42 p.m. Aug. 30, 2007 - Val Brickates Kennedy
Neuralstem teams up with U Mich. for ALS research 8:26 a.m. Aug. 30, 2007 - Val Brickates Kennedy
Stem cell industry trying to see silver lining in funding fight 11:36 a.m. April 13, 2007 - Greg Presto

15 Biotech Names For 2015 2:37 p.m. Jan. 5, 2015 - Seeking Alpha
First Week Of August 21st Options Trading For Neuralstem (CUR) 11:32 a.m. Jan. 2, 2015 - TheStreet.com
Neuralstem (CUR) Stock Rises Today as Brainstorm Cell Therapeutics Soars 11:02 a.m. Jan. 2, 2015 - TheStreet.com
One Reason Neuralstem (CUR) Stock is Rising Today 12:42 p.m. Dec. 31, 2014 - TheStreet.com
Brainstorm Cell up on clinical trial results 10:25 a.m. Dec. 31, 2014 - Seeking Alpha
InVivo Therapeutics 4:56 p.m. Nov. 12, 2014 - Seeking Alpha
10-Q: NEURALSTEM, INC. 6:37 a.m. Nov. 7, 2014 - Edgar Online - (EDG = 10Q, 10K)
Cytokinetics ALS drug impacts disease progression in Phase 2b trial 9:57 a.m. Oct. 20, 2014 - Seeking Alpha
Genervon ALS drug shows encouraging results 7:27 a.m. Oct. 20, 2014 - Seeking Alpha
InVivo, Neuralstem Treat Spinal Cord Injury Patients 12:53 p.m. Oct. 16, 2014 - Seeking Alpha
Brainstorm CEO Offers Investors a Frank Outlook for ALS Therapy 7:30 a.m. Oct. 16, 2014 - TheStreet.com
First patient dosed in spinal cord injury stem cell trial 9:32 a.m. Oct. 10, 2014 - Seeking Alpha
Investigator presents NSI-566 follow up data 11:52 a.m. Sept. 22, 2014 - Seeking Alpha
Asterias cleared for stem cell trial in spinal cord injury 6:52 a.m. Aug. 27, 2014 - Seeking Alpha
Why Neuralstem Has Plenty Of Upside In The Short Term 7:29 a.m. Aug. 26, 2014 - Seeking Alpha
StemCells, Inc: Short-Term Noise Creates Another Buying Opportunity 7:14 a.m. Aug. 15, 2014 - Seeking Alpha
10-Q: NEURALSTEM, INC. 5:24 a.m. Aug. 8, 2014 - Edgar Online - (EDG = 10Q, 10K)
Researchers Fret as Social Media Lift Drug-Trial Veil 9:30 p.m. July 29, 2014 - The Wall Street Journal Interactive Edition
Second site begins enrolling patients in BrainStorm ALS trial 10:05 a.m. July 15, 2014 - Seeking Alpha
Behind The Promotion Of Northwest Bio 8:35 a.m. July 7, 2014 - Seeking Alpha

Neuralstem To Present At Biotech Showcase 2015 9:03 a.m. Jan. 6, 2015 - PR Newswire - PRF
Neuralstem Announces Publication Of Long Term Cell Survival From Phase I NSI-566 ALS Study In The Journal "Annals Of Clinical And Translational Neurology" 9:00 a.m. Nov. 10, 2014 - PR Newswire - PRF
Neuralstem Reports Third Quarter Financial Results And Provides Business And Clinical Update 9:00 a.m. Nov. 7, 2014 - PR Newswire - PRF
First Patient Treated In Neuralstem Phase I Spinal Cord Injury Stem Cell Trial Through The UC San Diego Sanford Stem Cell Clinical Center 8:15 a.m. Oct. 9, 2014 - PR Newswire - PRF
Neuralstem ALS Investigator Presents Long-Term Follow Up Phase I Data 8:15 a.m. Sept. 22, 2014 - PR Newswire - PRF
Neuralstem President And CEO To Present At The 2014 Rodman & Renshaw Annual Global Investment Conference 8:15 a.m. Sept. 5, 2014 - PR Newswire - PRF
Neuralstem Reports Second Quarter Financial Results And Provides Business And Clinical Update 7:00 a.m. Aug. 8, 2014 - PR Newswire - PRF
Final Patient Treated In Neuralstem Phase II ALS Stem Cell Trial 8:15 a.m. Aug. 4, 2014 - PR Newswire - PRF
Morning Briefing on Biotech Stocks -- Research on Dynavax Technologies, Synergy Pharma, Infinity Pharma, and Neuralstem 6:00 a.m. July 2, 2014 - PR Newswire - PRF
Neuralstem's NSI-189 Novel Neurogenic Compound Shows Significant Effect In Major Depressive Disorder 8:15 a.m. June 25, 2014 - PR Newswire - PRF
Neuralstem NSI-189 Select Data To Be Presented At Neuropsychopharmacology Congress 8:15 a.m. June 19, 2014 - PR Newswire - PRF
Neuralstem Final Phase I Depression Data Presented At The American Society Of Clinical Psychopharmacology Annual Meeting 8:15 a.m. June 18, 2014 - PR Newswire - PRF
Neuralstem, Inc. - "The FDA is Not the Enemy" 8:26 a.m. June 9, 2014 - ACCESSWIRE
Morning Briefing on Top Gainers -- Research on GTx Inc., Iridium Communications, Neuralstem, and Idera Pharma 5:50 a.m. May 29, 2014 - PR Newswire - PRF
Neuralstem, Inc. - "Most men would rather deny a hard truth than face it" 10:36 a.m. May 28, 2014 - ACCESSWIRE
Neuralstem Depression Trial Data to Be Presented at The American Society of Clinical Psychopharmacology Annual Meeting 8:28 a.m. May 23, 2014 - PR Newswire - PRF
Neuralstem Reports First Quarter Financial Results And Provides Business And Clinical Update 8:15 a.m. May 12, 2014 - PR Newswire - PRF
Technical Data on Top Gainers -- Research on Assured Guaranty, Ampio Pharma, Neuralstem, and Kennedy-Wilson Holdings 12:34 p.m. May 9, 2014 - PR Newswire - PRF
Neuralstem Appoints Sandford Drexel Smith, Former Genzyme Executive Vice President, To Board Of Directors 8:15 a.m. May 8, 2014 - PR Newswire - PRF
Neuralstem Spinal Cord Injury Stem Cell Trial Approved To Commence At University Of California, San Diego 8:15 a.m. April 16, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Firefox Champions Privacy with Iconic Internet Campaign

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Sintilimab Poised for New Milestone in Melanoma Fight

An Opening Shot: NMPA's Decision Window Well, here's the latest chapter in the saga of battling advanced melanoma with some real gritty numbers behind it. Innovent Biologics has thrown its hat back in the ring with news that the China National Medical Products Administration (NMPA) has embraced a new indication application for their drug sintilimab. They're teaming it up...

Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Vantrue's Black Friday Dash Cam Deals: Save up to 44%

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

HCLTech Partners with Rapidus on Semiconductor Future

Making Sense of the HCLTech and Rapidus Collaboration When you're talking about the world of semiconductors, no two words get tossed around more than innovation and speed. Now, with the recent partnership between HCLTech and Rapidus, those words are bound to echo from India to Japan and beyond. We have HCLTech, a stalwart of global technology, teaming up with Rapidus, a...

Hims & Hers Faces FTC Heat: Investor Class Action Looms

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

D-Wave Investors Must Decide by Dec 15 Class Suit

Facing the Class Action Deadline There's nothing like a looming deadline to stir the pot, and that's exactly what's happening with D-Wave Quantum Inc. (NASDAQ: QBTS) as it faces the heat of a class action lawsuit. Investors who got caught in the slide between February 26, 2026, and August 25, 2026, need to sharpen their pencils and mark December 15, 2026, on their...

Clarins Dazzles Austin with Skin Longevity Event

Clarins Takes Austin by Storm Under the vast Austin sky, something remarkable unfolded as Clarins transformed the scene with a flashy rooftop affair that screamed innovation and elegance. They weren’t just showing off fancy bottles of beauty potion; they were stirring the pot, merging science with a splash of high-end glitz. This wasn’t just another product pitch—it...

BAIC FOTON Eyes African Market with Strategic Moves

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Dar Global Eyes Dubai for Strategic Real Estate Moves

Tapping into Dubai's Real Estate Allure Every seasoned investor knows the real estate game ain't for the faint of heart, especially when you’re playing in a market as competitive as Dubai's. But here comes Dar Global Capital Partners (DGCP), throwing their hat into the ring with a fresh strategy centered around high-value real estate. Sure, they aren't new to the...